Skip to main content

Featured

Best Low-Cost ETFs for Canadian Investors in 2026 — Complete Guide

  Published: April 2026 | Reading time: 12 min | Category: Investing, Personal Finance, RRSP, TFSA If you want to build long-term wealth in Canada without paying a financial advisor 1–2% of your portfolio every year, low-cost ETFs are the answer. A single well-chosen ETF can give you instant exposure to hundreds or thousands of companies worldwide — for as little as 0.20% in annual fees. This guide covers the best ETFs available to Canadian investors in 2026 — for your TFSA, RRSP, and non-registered accounts — with clear explanations of what each one holds, what it costs, and who it's best for. Why Low-Cost ETFs Beat Most Other Investments for Canadians Before getting into specific funds, here's why this matters so much. The fee problem with mutual funds The average Canadian mutual fund charges a Management Expense Ratio (MER) of 2–2.5% per year. That might sound small, but on a $200,000 portfolio it's $4,000–$5,000 leaving your account every single year — regar...
Post a Comment
Read more

article

Labels

Trump’s Tariff Blitz: Pharmaceuticals and Chips in the Crosshairs

The Trump administration has launched investigations into imports of pharmaceuticals and semiconductors, citing national security concerns. These probes, initiated under Section 232 of the Trade Expansion Act of 1962, aim to impose tariffs to reduce reliance on foreign production. Pharmaceuticals and semiconductors, which are largely sourced from countries like India, China, and Taiwan, are seen as critical to U.S. security. While the administration argues that tariffs will boost domestic manufacturing, critics warn of potential shortages and increased costs for consumers. 

The move follows exemptions for smartphones and computers from steep reciprocal tariffs, signaling a strategic shift in trade policy. As markets react to these developments, the global economic landscape faces uncertainty. 



Labels:

Comments

Post a Comment